BRIEF-Roche Says FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay

Reuters · 02/08/2021 06:07
BRIEF-Roche Says FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay

- Roche Holding AG ROG.S:

  • FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION FOR ROCHE'S ELECSYS GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) ASSAY TO HELP IDENTIFY PATIENTS SUITABLE FOR INNOVATIVE TREATMENT ADDRESSING UNINTENTIONAL WEIGHT LOSS IN CANCER PATIENTS

Source text for Eikon: ID:nNDL2tysLq

Further company coverage: ROG.S


(Berlin Speed Desk)

((frankfurt.newsroom@thomsonreuters.com;))